Watch Ticker

MediWound Ltd.

Go to MediWound Ltd. Website

$18.37

0.00 (0.00%)

Live

Previous Close

$18.37

Day Range

$0 - $0

Previous Day Range

$17.12 - $19.12

Market Cap

$200.3 million USD

Day Vol.

Previous Day Vol.

253313

Currency

USD

Primary Exchange

Nasdaq

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connect...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers

MediWound has initiated a global Phase III trial to evaluate the efficacy and safety of its wound debridement therapy EscharEx for the treatment of venous leg ulcers. The trial aims to assess EscharEx's ability to effectively debride chronic wounds and prepare the wound bed for healing.

Related tickers: MDWD, SOLV, MDXG.

Read Full Article

Editornatashya Angelica - MediWound shares hold Buy rating from TD Cowen on significant grant - Investing.com

MediWound Ltd. has received a €16.25 million grant from the European Innovation Council, which is expected to accelerate the development of its product EscharEx for Diabetic Foot Ulcers. TD Cowen has maintained a Buy rating on MediWound's stock with a $25.00 price target.

Related tickers: MDWD.

Read Full Article

Trending Tickers

Please sign in to view